Scinovex
article Open Access

Retrospective review of COVID-19 patients with mucormycosis

International Journal of Otolaryngology Research · 2021 · Vol. 3(1) · pp. 05–06

Abstract

Introduction: India is also facing a new challenge in form of COVID-19 associated mucormycosis. It is a rare but fatal infection if not treated. It is often referred as black fungus. Aim: The present study reviewed COVID-19 associated mucormycosis in a tertiary care centre. Methods: This retrospective study included COVID-19 positive patients confirmed on RT-PCR during the period of one month (May 2021) at Bangalore Medical College, Bangalore, Karnataka. Results: Male to female ratio was 2.6:1. 53.2% complained of decreased vision while 23.4% had nasal discharge. 85% patients were diabetic, and 29.8% were hypertensive. Thirteen patients underwent sinus endoscopy, and all of them showed black discoloration, yellowish discharge, and eschar. Conclusion: COVID-19 associated mucormycosis is a serious problem, and early diagnosis and treatment of these patients are required for successful management.

Antifungal resistance and susceptibilityLong-Term Effects of COVID-19MucormycosisMedicineEscharRetrospective cohort studyCoronavirus disease 2019 (COVID-19)Tertiary careSinus (botany)SurgeryDermatologyInternal medicine
Citations
0
FWCI
0.00
field-weighted impact
References
0
Percentile
23%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.